Evidence map›Paper›PMID 27583971›Full record

ArticlePloS one2016

Optimal Design of Low-Density SNP Arrays for Genomic Prediction: Algorithm and Applications.

Xiao-Lin Wu, Jiaqi Xu, Guofei Feng, George R Wiggans, Jeremy F Taylor, Jun He, Changsong Qian, Jiansheng Qiu, Barry Simpson, Jeremy Walker and 1 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Estimation of ryegrass (Frontiers in plant science · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiao-Lin WuBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.
Jiaqi XuBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.
Guofei FengBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.
George R WiggansAnimal Genomics and Improvement Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, Maryland, United States of America.
Jeremy F TaylorDivision of Animal Sciences, University of Missouri, Columbia, Missouri, United States of America.
Jun HeCollege of Animal Sciences and Technology, Hunan Agricultural University, Changsha, China.
Changsong QianMarketing and Business Development, Neogen Bio-Scientific Technology (Shanghai) Company Ltd., Shanghai, China.
Jiansheng QiuBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.
Barry SimpsonBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.
Jeremy WalkerBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.
Stewart BauckBioinformatics and Biostatistics, GeneSeek (a Neogen Company), Lincoln, Nebraska, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-density (LD) single nucleotide polymorphism (SNP) arrays provide a cost-effective solution for genomic prediction and selection, but algorithms and computational tools are needed for the optimal design of LD SNP chips. A multiple-objective, local optimization (MOLO) algorithm was developed for design of optimal LD SNP chips that can be imputed accurately to medium-density (MD) or high-density (HD) SNP genotypes for genomic prediction. The objective function facilitates maximization of non-gap map length and system information for the SNP chip, and the latter is computed either as locus-averaged (LASE) or haplotype-averaged Shannon entropy (HASE) and adjusted for uniformity of the SNP distribution. HASE performed better than LASE with ≤1,000 SNPs, but required considerably more computing time. Nevertheless, the differences diminished when >5,000 SNPs were selected. Optimization was accomplished conditionally on the presence of SNPs that were obligated to each chromosome. The frame location of SNPs on a chip can be either uniform (evenly spaced) or non-uniform. For the latter design, a tunable empirical Beta distribution was used to guide location distribution of frame SNPs such that both ends of each chromosome were enriched with SNPs. The SNP distribution on each chromosome was finalized through the objective function that was locally and empirically maximized. This MOLO algorithm was capable of selecting a set of approximately evenly-spaced and highly-informative SNPs, which in turn led to increased imputation accuracy compared with selection solely of evenly-spaced SNPs. Imputation accuracy increased with LD chip size, and imputation error rate was extremely low for chips with ≥3,000 SNPs. Assuming that genotyping or imputation error occurs at random, imputation error rate can be viewed as the upper limit for genomic prediction error. Our results show that about 25% of imputation error rate was propagated to genomic prediction in an Angus population. The utility of this MOLO algorithm was also demonstrated in a real application, in which a 6K SNP panel was optimized conditional on 5,260 obligatory SNP selected based on SNP-trait association in U.S. Holstein animals. With this MOLO algorithm, both imputation error rate and genomic prediction error rate were minimal.

Indexed as

AlgorithmsGenomicsPolymorphism, Single NucleotideAnimalsCattleChromosomesHeuristicsOligonucleotide Array Sequence Analysis

Identifiers

PMID27583971
PMCPMC5008792

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.